Dec. 5, 2022 – The respiratory syncytial virus (RSV) “season” this year is notable for a number of reasons, including the relatively early and large spike in cases that is challenging the capacity of children’s hospitals nationwide.
But the spotlight on pediatric cases is overshadowing how this virus also raises risk for people 65 and older. RSV in older Americans “remains under-recognized by both physicians and especially the public,” says Ann R. Falsey, MD, a professor at the University of Rochester School of Medicine in New York.
Even the family of the president of the National Foundation for Infectious Diseases has not been…
